Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model
Susanne Siebeneicher(Paul Ehrlich Institut), Masako Toda(Tohoku University), Stephan Scheurer(Paul Ehrlich Institut), Andrea Wangorsch(Paul Ehrlich Institut), Seishiro Naito(National Institute of Infectious Diseases), Stefan Vieths(Paul Ehrlich Institut), A Heinz(Johannes Gutenberg University Mainz), Christian Taube(Ruhrlandklinik), Sonja Wolfheimer(Paul Ehrlich Institut), Sebastian Reuter(Johannes Gutenberg University Mainz), Joachim Maxeiner(University Medical Center of the Johannes Gutenberg University Mainz), Stefan Schülke(Paul Ehrlich Institut), Maren Krause(Paul Ehrlich Institut)
Cited by 45
Related Papers
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
|Cells|2020|899
Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells
|Immunity|2010|539
Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells
|Journal of Clinical Investigation|2011|468
DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori–specific immune tolerance, and asthma protection
|Journal of Clinical Investigation|2012|314
Eosinophilic and Noneosinophilic Asthma
|CHEST Journal|2021|262